Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 1;28(1):64-74.
doi: 10.1097/MED.0000000000000588.

Growth, body composition, and endocrine issues in Williams syndrome

Affiliations
Review

Growth, body composition, and endocrine issues in Williams syndrome

Takara L Stanley et al. Curr Opin Endocrinol Diabetes Obes. .

Abstract

Purpose of review: Williams syndrome is a multisystem disorder caused by a microdeletion on chromosome 7q. Throughout infancy, childhood, and adulthood, abnormalities in body composition and in multiple endocrine axes may arise for individuals with Williams syndrome. This review describes the current literature regarding growth, body composition, and endocrine issues in Williams syndrome with recommendations for surveillance and management by the endocrinologist, geneticist, or primary care physician.

Recent findings: In addition to known abnormalities in stature, calcium metabolism, and thyroid function, individuals with Williams syndrome are increasingly recognized to have low bone mineral density, increased body fat, and decreased muscle mass. Furthermore, recent literature identifies a high prevalence of diabetes and obesity starting in adolescence, and, less commonly, a lipedema phenotype in both male and female individuals. Understanding of the mechanisms by which haploinsufficiency of genes in the Williams syndrome-deleted region contributes to the multisystem phenotype of Williams syndrome continues to evolve.

Summary: Multiple abnormalities in growth, body composition, and endocrine axes may manifest in individuals with Williams syndrome. Individuals with Williams syndrome should have routine surveillance for these issues in either the primary care setting or by an endocrinologist or geneticist.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: No authors have any relevant conflicts of interest.

Figures

Figure 1:
Figure 1:
Lipedema phenotype in an adult woman with WS. Left panel shows whole body dual-energy x-ray absorptiometry (DXA) scan, with yellow indicating fat mass, red indicating lean mass, and blue indicating bone mass. Right panel shows clinical photograph while seated. In both the DXA scan and the photograph, characteristic “cuffing” of subcutaneous fat is seen at the ankles, with the feet spared from fat accumulation. Reprinted with permission from Shaikh et al. (18); copyright John Wiley & Sons Ltd.

References

    1. Pober BR. Williams-Beuren syndrome. N Engl J Med. 2010;362(3):239–52. - PubMed
    1. Morris CA, Braddock SR, Council On G. Health Care Supervision for Children With Williams Syndrome. Pediatrics. 2020;145(2). - PubMed
    2. These comprehensive guidelines for care of children and adults with WS update the previous 2001 guidelines and offer providers concise recommendations on surveillance and management, including for the multiple endocrine abnormalities associated with WS.

    1. Ewart AK, Morris CA, Atkinson D, Jin W, Sternes K, Spallone P, et al. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet. 1993;5(1):11–6. - PubMed
    1. Schubert C The genomic basis of the Williams-Beuren syndrome. Cell Mol Life Sci. 2009;66(7):1178–97. - PMC - PubMed
    1. Levy-Shraga Y, Gothelf D, Pinchevski-Kadir S, Katz U, Modan-Moses D. Endocrine manifestations in children with Williams-Beuren syndrome. Acta Paediatr. 2018;107(4):678–84. - PubMed

Publication types